C
Carlo M. Croce
Researcher at Ohio State University
Publications - 1156
Citations - 199822
Carlo M. Croce is an academic researcher from Ohio State University. The author has contributed to research in topics: microRNA & Cancer. The author has an hindex of 198, co-authored 1135 publications receiving 189007 citations. Previous affiliations of Carlo M. Croce include University of Nebraska Medical Center & University of California, Los Angeles.
Papers
More filters
Journal ArticleDOI
Abrogation of esophageal carcinoma development in miR-31 knockout rats.
Louise Y.Y. Fong,Cristian Taccioli,Alexey Palamarchuk,Guidantonio Malagoli Tagliazucchi,Ruiyan Jing,Karl J. Smalley,Sili Fan,Joseph Altemus,Oliver Fiehn,Kay Huebner,John L. Farber,Carlo M. Croce +11 more
TL;DR: The identification of EGLN3, a known negative regulator of nuclear factor κB (NF-κB), as a direct target of miR-31 establishes a functional link between oncomiR- 31, tumor suppressor target EGLn3, and up-regulated NF-κb–controlled inflammation signaling.
Journal ArticleDOI
Will Detection of MicroRNA Biomarkers in Blood Improve the Diagnosis and Survival of Patients With Pancreatic Cancer
TL;DR: The detection of pancreatic cancer– associated biomarkers in blood, serum, or plasma at an early stage offers the possibility for early diagnosis and an opportunity to reduce mortality from Pancreatic cancer.
Journal ArticleDOI
A LIF/Nanog axis is revealed in T lymphocytes that lack MARCH-7, a RINGv E3 ligase that regulates the LIF-receptor
Lorraine H. Thompson,Roy A. Whiston,Yerzhan Rakhimov,Cristian Taccioli,Chang Gong Liu,Carlo M. Croce,Su M. Metcalfe +6 more
TL;DR: In the absence of MARCH-7 a new signalling pathway is unmasked that involves Nanog expression in the T cell lineage, and this is the first demonstration that T cells retain responsiveness to a LIF/Nanog axis.
Journal Article
Somatic Cell Hybrids Between Mouse Peritoneal Macrophages and SV40-Transformed Human Cells: III. Identification of Surface Antigens Coded for by Human Chromosomes 7 and 17
Lucienne Cicurel,Carlo M. Croce +1 more
TL;DR: Using a sensitive radioimmunoassay, it was able to identify noncross-reactive cell-surface antigen(s) specifically coded for by either human chromosome 7 or 17, and present in normal, tumor-derived and virus-transformed human cells, but no reactivity against SV40 tumor-specific surface antigen (TSSA) could be detected in the antisera.